Preface |
|
xiv | |
Acknowledgments |
|
xv | |
Author biographies |
|
xvi | |
|
1 History, scope and development of biotechnology |
|
|
1 | (1) |
|
|
1 | (4) |
|
1.2 Branches of biotechnology |
|
|
5 | (1) |
|
1.3 Biotechnology and its various stages of development |
|
|
6 | (21) |
|
1.3.1 Old and new biotechnology |
|
|
17 | (1) |
|
1.3.2 Ancient biotechnology (pre-1800) |
|
|
17 | (2) |
|
1.3.3 Classical biotechnology |
|
|
19 | (2) |
|
1.3.4 Modern biotechnology |
|
|
21 | (6) |
|
1.4 Scope and importance of biotechnology |
|
|
27 | (2) |
|
1.4.1 Biotechnology in medicine |
|
|
27 | (1) |
|
1.4.2 Industrial biotechnology |
|
|
28 | (1) |
|
1.4.3 Biotechnology and the environment |
|
|
29 | (1) |
|
1.4.4 Biotechnology and agriculture |
|
|
29 | (1) |
|
1.5 Biotechnology techniques |
|
|
29 | (5) |
|
|
29 | (1) |
|
|
29 | (2) |
|
1.5.3 Liposome-based delivery |
|
|
31 | (1) |
|
1.5.4 Cell or tissue culture |
|
|
32 | (1) |
|
1.5.5 Genetic engineering |
|
|
32 | (1) |
|
|
32 | (1) |
|
|
32 | (1) |
|
1.5.8 Artificial insemination and ET technology |
|
|
33 | (1) |
|
1.5.9 Stem cell technology |
|
|
33 | (1) |
|
1.6 Applications of biotechnology |
|
|
34 | (13) |
|
1.6.1 Basic applications of biotechnology |
|
|
35 | (1) |
|
1.6.2 Most common applications |
|
|
35 | (12) |
|
1.7 Biotech research: 2015-2016 |
|
|
47 | |
|
|
57 | |
|
2 Modern DNA science and its applications |
|
|
1 | (1) |
|
|
1 | (2) |
|
2.1.1 Genes: units of inheritance |
|
|
1 | (2) |
|
2.2 The Human Genome Project |
|
|
3 | (1) |
|
2.3 DNA synthesis begins at replication origins |
|
|
4 | (1) |
|
|
4 | (2) |
|
2.4.1 One gene, one product |
|
|
4 | (2) |
|
|
6 | (1) |
|
2.5.1 Basic structural features of DNA |
|
|
7 | (1) |
|
|
7 | (2) |
|
|
8 | (1) |
|
|
9 | (1) |
|
|
9 | (1) |
|
2.8 Repair and recombination |
|
|
9 | (2) |
|
|
11 | (3) |
|
2.9.1 Base excision repair (BER) |
|
|
13 | (1) |
|
2.9.2 Mismatch repair (MMR) |
|
|
13 | (1) |
|
2.9.3 Nucleotide excision repair (NER) |
|
|
14 | (1) |
|
2.9.4 Double-strand break (DSB) repair |
|
|
14 | (1) |
|
|
14 | (2) |
|
2.10.1 Types and examples of recombination |
|
|
15 | (1) |
|
2.11 DNA isolation is the commencement of molecular marker analysis |
|
|
16 | (2) |
|
2.11.1 DNA extraction protocols |
|
|
17 | (1) |
|
2.12 Types of molecular markers |
|
|
18 | (16) |
|
2.12.1 Hybridization-based molecular markers |
|
|
18 | (4) |
|
|
22 | (12) |
|
2.13 Genomic library screening methods |
|
|
34 | (10) |
|
2.13.1 Colony hybridization |
|
|
34 | (1) |
|
2.13.2 Chromosome walking |
|
|
35 | (1) |
|
2.13.3 Blotting techniques |
|
|
36 | (1) |
|
2.13.4 Southern blot analysis |
|
|
36 | (1) |
|
2.13.5 Northern blot analysis |
|
|
36 | (1) |
|
2.13.6 Western blot analysis |
|
|
37 | (1) |
|
2.13.7 Dot blot technique |
|
|
37 | (1) |
|
2.13.8 Techniques for the detection of specific proteins |
|
|
38 | (1) |
|
2.13.9 Electrophoresis techniques |
|
|
38 | (6) |
|
2.14 Triplex DNA, TFOS, PNAs, RNA-DNA hybrids and DSRNA/RNAI |
|
|
44 | (2) |
|
2.15 Isolation, sequencing and synthesis of genes |
|
|
46 | (8) |
|
2.15.1 Isolation of ribosomal RNA |
|
|
46 | (1) |
|
2.15.2 Isolation of genes coding for specific proteins |
|
|
46 | (1) |
|
2.15.3 Isolation of genes (with known or unknown products) using DNA or RNA probes |
|
|
47 | (1) |
|
2.15.4 Isolation of genes (with known or unknown products) using DNA or RNA probes |
|
|
48 | (1) |
|
2.15.5 Use of transposable elements (transposon tagging) |
|
|
49 | (1) |
|
2.15.6 T-DNA insertion mutagenesis for isolation of plant genes |
|
|
50 | (1) |
|
2.15.7 Promoter, enhancer and gene trap for isolation of genes |
|
|
50 | (1) |
|
2.15.8 Mutation complementation |
|
|
51 | (1) |
|
2.15.9 Differential screening and differential display technique for isolation of genes |
|
|
51 | (1) |
|
2.15.10 Subtractive hybridization for gene isolation |
|
|
52 | (1) |
|
2.15.11 Map-based cloning for gene isolation |
|
|
52 | (1) |
|
2.15.12 Isolation of novel genes |
|
|
52 | (1) |
|
2.15.13 Sequencing of a gene or a DNA fragment |
|
|
53 | (1) |
|
|
54 | (6) |
|
2.16.1 Chemical synthesis of tRNA genes |
|
|
54 | (2) |
|
2.16.2 Synthesis of the gene for yeast alanyl tRNA |
|
|
56 | (1) |
|
2.16.3 Synthesis of a gene from true precursor tRNA |
|
|
56 | (1) |
|
2.16.4 Mass spectrometry for genomics and proteomics |
|
|
56 | (4) |
|
2.17 Genomics and proteomics research |
|
|
60 | |
|
|
61 | |
|
3 Introduction to genetic engineering |
|
|
1 | (1) |
|
|
1 | (1) |
|
3.2 Gene transfer technologies |
|
|
2 | (7) |
|
|
2 | (1) |
|
|
3 | (1) |
|
3.2.3 Biolistics or microprojectiles for DNA transfer |
|
|
3 | (1) |
|
3.2.4 Liposome-mediated gene transfer |
|
|
4 | (1) |
|
3.2.5 Calcium-phosphate-mediated DNA transfer |
|
|
4 | (1) |
|
3.2.6 DNA transfer by DEAE-dextran method |
|
|
5 | (1) |
|
3.2.7 Transfer of DNA by polycation-DMSO |
|
|
6 | (1) |
|
3.2.8 Polyethylene-glycol-mediated transfection |
|
|
7 | (1) |
|
3.2.9 Gene transfer through peptides |
|
|
7 | (1) |
|
3.2.10 Gene transfer by retroviruses |
|
|
8 | (1) |
|
|
9 | (1) |
|
3.4 Different hosts and protein expression technologies |
|
|
10 | (5) |
|
|
12 | (3) |
|
|
15 | (1) |
|
3.6 Transfection methods and transgenic animals |
|
|
16 | (14) |
|
3.6.1 Gene transfer or transfection |
|
|
17 | (1) |
|
3.6.2 Transfection of fertilized eggs or embryos |
|
|
17 | (1) |
|
3.6.3 Transfer of whole nuclei (or split embryos) |
|
|
17 | (1) |
|
3.6.4 DNA microinjection into the egg |
|
|
18 | (1) |
|
3.6.5 Virus-mediated gene transfer to embryo |
|
|
19 | (1) |
|
3.6.6 Transfection of cultured mammalian cells |
|
|
20 | (1) |
|
3.6.7 Targeted gene transfer |
|
|
21 | (1) |
|
3.6.8 Transgenic animals in biotechnology |
|
|
21 | (9) |
|
3.7 Applications of genetic engineering in biotechnology |
|
|
30 | (2) |
|
3.8 Mammalian cell line characterization |
|
|
32 | (1) |
|
3.9 In vitro fertilization (IVF) and embryo transfer in humans and domestic animals |
|
|
33 | (1) |
|
3.10 IVF in humans and embryo transfer |
|
|
34 | (14) |
|
3.10.1 Types and causes of infertility |
|
|
34 | (3) |
|
3.10.2 Evaluation and assessment of patients |
|
|
37 | (1) |
|
3.10.3 IVF fertility treatment |
|
|
38 | (1) |
|
3.10.4 Development of ovarian follicles in natural menstrual cycles |
|
|
39 | (1) |
|
3.10.5 Development of ovarian follicles in stimulated cycles |
|
|
39 | (1) |
|
3.10.6 Development of ovarian follicles during a controlled cycle |
|
|
40 | (1) |
|
3.10.7 Ovarian stimulation protocols for IVF |
|
|
40 | (3) |
|
3.10.8 Spontaneous luteinizing hormone (LH) surge |
|
|
43 | (1) |
|
3.10.9 Administration of hCG for controlled ovulation |
|
|
43 | (1) |
|
3.10.10 Equipment and technique for laparoscopy |
|
|
44 | (1) |
|
3.10.11 Oocyte culture and IVF culture of oocytes |
|
|
45 | (1) |
|
3.10.12 Preparation of semen |
|
|
46 | (1) |
|
3.10.13 In vitro fertilization |
|
|
47 | (1) |
|
3.11 Embryo transfer (ET) in humans |
|
|
48 | (2) |
|
|
48 | (1) |
|
|
48 | (2) |
|
3.12 Superovulation, IVF and embryo culture in farm animals |
|
|
50 | (2) |
|
|
52 | |
|
3.13.1 ET technique in cattle |
|
|
52 | (2) |
|
3.13.2 Technique for freezing embryos in cattle |
|
|
54 | (1) |
|
3.13.3 Benefits of ET in cattle |
|
|
55 | (1) |
|
|
55 | |
|
4 Applications of stem cells in disease and gene therapy |
|
|
1 | (1) |
|
|
1 | (1) |
|
4.2 Types of gene therapy |
|
|
2 | (1) |
|
4.2.1 Somatic gene therapy |
|
|
2 | (1) |
|
4.2.2 Germline gene therapy |
|
|
3 | (1) |
|
4.3 Gene therapy strategies |
|
|
3 | (2) |
|
4.3.1 Gene augmentation therapy (GAT) |
|
|
3 | (1) |
|
4.3.2 Targeted killing of specific cells |
|
|
4 | (1) |
|
4.3.3 Targeted inhibition of gene expression |
|
|
5 | (1) |
|
4.3.4 Targeted gene mutation correction |
|
|
5 | (1) |
|
4.4 Methods of gene therapy |
|
|
5 | (3) |
|
4.4.1 Ex vivo gene therapy |
|
|
6 | (1) |
|
4.4.2 In vivo gene therapy |
|
|
7 | (1) |
|
4.5 Gene therapy approaches |
|
|
8 | (2) |
|
4.5.1 Conventional gene therapy |
|
|
10 | (1) |
|
4.5.2 Non-classical gene therapy |
|
|
10 | (1) |
|
4.6 Vectors for gene therapy |
|
|
10 | (9) |
|
4.6.1 Viral-mediated gene delivery |
|
|
10 | (1) |
|
4.6.2 Non-viral-mediated gene therapy |
|
|
11 | (8) |
|
4.7 Target sites for gene therapy |
|
|
19 | (1) |
|
4.7.1 Target cells for gene transfer |
|
|
19 | (1) |
|
4.8 Gene therapy strategies for cancer |
|
|
20 | (2) |
|
4.8.1 Tumor necrosis factor gene therapy |
|
|
20 | (1) |
|
4.8.2 Suicide gene therapy |
|
|
20 | (1) |
|
4.8.3 Two gene cancer therapy |
|
|
21 | (1) |
|
4.8.4 Gene replacement therapy |
|
|
21 | (1) |
|
4.9 Gene therapy for AIDS |
|
|
22 | (1) |
|
|
22 | (1) |
|
4.9.2 Genes of HIV proteins |
|
|
22 | (1) |
|
4.9.3 Gene to inactivate gp120 |
|
|
22 | (1) |
|
4.10 Oligonucleotide therapies: antigene and antisense therapy |
|
|
22 | (4) |
|
4.10.1 Antisense therapy for cancer |
|
|
23 | (2) |
|
4.10.2 Antisense therapy for AIDS |
|
|
25 | (1) |
|
4.11 Antisense oligonucleotides as therapeutic agents |
|
|
26 | (1) |
|
4.12 Chimeric oligonucleotides in gene correction |
|
|
27 | (1) |
|
4.13 Aptamers as therapeutic agents |
|
|
28 | (1) |
|
4.14 Ribozymes as therapeutic agents |
|
|
29 | (1) |
|
4.15 The future of gene therapy |
|
|
29 | (1) |
|
|
30 | |
|
4.16.1 Stem cell classification |
|
|
30 | (2) |
|
4.16.2 Historical background of stem cell research |
|
|
32 | (1) |
|
4.16.3 Ethical issues associated with cell lines |
|
|
33 | (1) |
|
4.16.4 Applications of stem cell research |
|
|
33 | (1) |
|
|
34 | (1) |
|
|
35 | |
|
5 Transgenic animals in biotechnology |
|
|
1 | |
|
|
1 | (1) |
|
5.2 Major objectives of gene transfer |
|
|
2 | (1) |
|
|
2 | (6) |
|
5.3.1 Fish vectors in molecular genetics and biotechnology |
|
|
5 | (1) |
|
5.3.2 P element vectors/transposon |
|
|
5 | (2) |
|
5.3.3 Baculovirus as versatile vectors for protein expression in insects |
|
|
7 | (1) |
|
5.4 Efficient and versatile mammalian virus vectors |
|
|
8 | (9) |
|
|
8 | (6) |
|
5.4.2 BPV (bovine papillomavirus) DNA vectors |
|
|
14 | (1) |
|
5.4.3 Retrovirus vectors and their use |
|
|
14 | (2) |
|
5.4.4 Vaccinia virus vectors: new approach for producing recombinant vaccines |
|
|
16 | (1) |
|
5.4.5 Adenovirus vectors (for gene therapy, vaccination and cancer gene therapy) |
|
|
16 | (1) |
|
5.5 Mammalian artificial chromosome (MAC) vectors for somatic gene therapy |
|
|
17 | (1) |
|
|
18 | (6) |
|
|
19 | (1) |
|
5.6.2 Selectable reporter or marker genes |
|
|
19 | (5) |
|
5.7 Transfection methods: an approach towards mammalian cell transfection |
|
|
24 | (10) |
|
5.7.1 Calcium phosphate-mediated transfection of eukaryotic cells |
|
|
24 | (1) |
|
5.7.2 Transfection using DEAE-dextran |
|
|
25 | (1) |
|
5.7.3 Lipofection (lipid-mediated DNA transfection method) |
|
|
26 | (2) |
|
5.7.4 Bacterial protoplast fusion |
|
|
28 | (1) |
|
5.7.5 Gene transfer by electroporation |
|
|
28 | (2) |
|
5.7.6 Retrovirus-mediated gene transfer |
|
|
30 | (1) |
|
5.7.7 Basics of DNA microinjection |
|
|
31 | (3) |
|
5.8 Xenopus oocytes as a heterologous expression system |
|
|
34 | (1) |
|
5.9 ES cell-mediated gene transfer |
|
|
35 | (2) |
|
5.10 Targeted gene transfer or gene therapy in mammals |
|
|
37 | (8) |
|
5.10.1 Gene disruption by HR in mammals |
|
|
39 | (1) |
|
5.10.2 Gene targeting/replacement |
|
|
40 | (5) |
|
5.11 Transgene integration, organization and expression |
|
|
45 | (1) |
|
5.12 Transgene recovery in mammalian cells |
|
|
46 | (2) |
|
5.13 Cloned protein expression in mammalian cells |
|
|
48 | |
|
5.13.1 Expression vectors for mammalian cells |
|
|
50 | (6) |
|
5.13.2 Enhanced production of recombinant proteins |
|
|
56 | (4) |
|
5.13.3 Scale-up of protein purification (stages in downstream processing) |
|
|
60 | (3) |
|
|
63 | |